Revance Therapeutics Inc (RVNC)

[DewDiligence]

Hopefully this breaks the wedge and back to the teens.

You’re preaching in the wrong pew. I don’t especially care when RVNC makes it back to the teens as I fully expect RVNC to attain a much, much higher valuation in due course—i.e. a valuation commensurate with a profitable business in the rapidly growing aesthetic and therapeutic markets (#msg-173069736).